Community Health Worker Implementation of Transdiagnostic Evidence-based Mental Health Intervention for Spanish-speaking Latine Parents

January 28, 2026 updated by: University of Illinois at Chicago

Community Health Worker Implementation of Transdiagnostic Evidence-based Treatment in Spanish

The goal of this clinical trial is to learn if it is doable for community health workers (CHWs) to deliver a mental health intervention to Spanish-speaking Latine parents experiencing anxiety, depression, and/or traumatic stress. The main questions it aims to answer are (1) Is it doable for CHWs to deliver the mental health intervention and for Latine parents to participate in the intervention, and (2) does the CHW-delivered intervention work in reducing Latine parents' mental health symptoms.

Researchers will compare Latine parents receiving the intervention to Latine parents not receiving the intervention to see if the CHW-delivered intervention works to improve mental health symptoms.

Participants will:

  • Participate in up to 14 weekly 1-hour sessions of the mental health intervention delivered by a CHW. They will be randomized to receive the intervention immediately or after a 5-month delay.
  • Participants will complete questionnaires about their symptoms, family and child functioning, as well as about how doable, acceptable, and appropriate they found the intervention
  • Participants will also complete a recorded interview about their experience in the intervention

Study Overview

Status

Not yet recruiting

Study Type

Interventional

Enrollment (Estimated)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Erika L Gustafson, PhD
  • Phone Number: 312-355-0626
  • Email: gustafs6@uic.edu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

INCLUSION criteria for PATIENT participants are:

  • 18 years or older
  • Identifies as Latine
  • Is a caregiver to a child 18 years or younger old living in the same household
  • Preference for Spanish services
  • Symptom scores in the moderate range for depression, anxiety, and/or PTSD (based on Computerized Adaptive Tests for Mental Health (CAT-MH))

EXCLUSION criteria for PATIENT participants:

  • Presence of mania symptoms in the mild range or higher (based on CAT-MH responses)
  • Presence of psychosis symptoms in mild range or higher (based on CAT-MH responses)
  • Active suicidal ideation (based on CAT-MH responses)
  • Depression, anxiety, or PTSD symptoms in the severe range (based on CAT-MH responses)
  • Currently receiving psychotherapy services

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Immediate CETA
Participants will participate in up to 14 weekly 1-hour CETA sessions with a community health worker provider
CETA is a transdiagnostic evidence-based treatment (EBT) designed to be implemented in low-resource settings and delivered by lay providers with little to no prior mental health training (i.e., CHWs). CETA consists of 11 modules that address the most common mental health disorders, including depression, anxiety, and post-traumatic stress. Modules are based on common elements of EBT, and include topics of psychoeducation, behavioral activation, relaxation, cognitive restructuring, exposures, safety planning, and substance use reduction. Designed with non-specialists in mind, CETA materials follow a simple, concrete format, with a 1-5 page "manual" section and 1-2 page "steps sheet" for each module that includes goals, example wording, and guidance for in-session use during implementation. CETA has demonstrated effectiveness in RCTs around the world, but has yet to be examined in the US in the context of CHW implementation.
Other Names:
  • CETA
No Intervention: Delayed CETA
Participants will receive no treatment during a 5-month period while completing symptom measures mirroring those in the active treatment condition. After the delay, participants will be able to receive the treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient engagement
Time Frame: Through study completion; over the course of approximately up to 5 months of participant participation
Number of intervention sessions completed per patient
Through study completion; over the course of approximately up to 5 months of participant participation
Fidelity
Time Frame: Completed after each CETA session through study completion, over the course of approximately up to 5 months of participant participation
CETA Fidelity Monitory System: Session information is documented by the CETA provider, who is trained to document what they did in each session relating to specific steps outlined in each CETA element. Each element in the CETA manual is executed through detailed "steps". Fidelity includes what CETA elements are chosen, when they are delivered, steps completed within each element, and the frequency in which each element is delivered.
Completed after each CETA session through study completion, over the course of approximately up to 5 months of participant participation
Patient intervention retention
Time Frame: Through study completion; over the course of approximately up to 5 months of participant participation
Number of patients who begin the intervention and go on to complete the intervention
Through study completion; over the course of approximately up to 5 months of participant participation
Patient control retention
Time Frame: Through study completion; over the course of approximately up to 5 months of participant participation
Number of participants assigned to the control condition who remain enrolled at the end of the 5-month delay period
Through study completion; over the course of approximately up to 5 months of participant participation
Patient assessment completion
Time Frame: Through study completion; over the course of approximately up to 5 months of participant participation
Proportion of planned assessments that are completed by patients
Through study completion; over the course of approximately up to 5 months of participant participation
Patient intervention feasibility, acceptability, & appropriateness
Time Frame: Patients will complete the mhIST immediately after their last intervention session
The Mental Health Implementation Science Tools (mhIST), consumer version measures domains of acceptability, appropriateness, and feasibility via self-report by those receiving an intervention. The mhIST uses a four-point Likert scale with the options of "Not at all," "A little bit," "A moderate amount," and "A lot."
Patients will complete the mhIST immediately after their last intervention session
Provider intervention feasibility, acceptability, & appropriateness
Time Frame: After approximately 2 years of intervention delivery
The Mental Health Implementation Science Tools (mhIST), provider version measures domains of acceptability, appropriateness, and feasibility via self-report by those delivering an intervention. The mhIST uses a four-point Likert scale with the options of "Not at all," "A little bit," "A moderate amount," and "A lot."
After approximately 2 years of intervention delivery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient mental health symptoms: Baseline
Time Frame: Baseline pre-randomization
Computerized Adaptive Testing (CAT) for Mental Health (CAT-MH): The CAT-MH is a suite of multidimensional item response theory (IRT) based CATs for the dimensional measurement of symptoms of depression, anxiety, and PTSD, amongst others. The CAT-MH generates a score and accompanying severity band for each disorder module based on patient report.
Baseline pre-randomization
Patient mental health symptoms: Monthly
Time Frame: Completed monthly while receiving the intervention or during the 5-month delay period (depending on randomization assignment)
Computerized Adaptive Testing (CAT) for Mental Health (CAT-MH): The CAT-MH is a suite of multidimensional item response theory (IRT) based CATs for the dimensional measurement of symptoms of depression, anxiety, and PTSD, amongst others. The CAT-MH generates a score and accompanying severity band for each disorder module based on patient report.
Completed monthly while receiving the intervention or during the 5-month delay period (depending on randomization assignment)
Patient mental health symptoms: Post-intervention
Time Frame: Completed immediately after the last intervention session
Computerized Adaptive Testing (CAT) for Mental Health (CAT-MH): The CAT-MH is a suite of multidimensional item response theory (IRT) based CATs for the dimensional measurement of symptoms of depression, anxiety, and PTSD, amongst others. The CAT-MH generates a score and accompanying severity band for each disorder module based on patient report.
Completed immediately after the last intervention session
Patient mental health symptoms: 1-month post-intervention
Time Frame: Completed 1 month after the last intervention session
Computerized Adaptive Testing (CAT) for Mental Health (CAT-MH): The CAT-MH is a suite of multidimensional item response theory (IRT) based CATs for the dimensional measurement of symptoms of depression, anxiety, and PTSD, amongst others. The CAT-MH generates a score and accompanying severity band for each disorder module based on patient report.
Completed 1 month after the last intervention session
Patient mental health symptoms: 3-months post-intervention
Time Frame: Completed 3 months after the last intervention session
Computerized Adaptive Testing (CAT) for Mental Health (CAT-MH): The CAT-MH is a suite of multidimensional item response theory (IRT) based CATs for the dimensional measurement of symptoms of depression, anxiety, and PTSD, amongst others. The CAT-MH generates a score and accompanying severity band for each disorder module based on patient report.
Completed 3 months after the last intervention session
Patient quality of life: Baseline
Time Frame: Baseline pre-randomization
World Health Organization Quality of Life - Abbreviated version (WHOQOL-BREF): patient-report of quality of life across domains of physical health, psychological health, social relationships, and environment, using a 5-point likert scale.
Baseline pre-randomization
Patient quality of life: Post-intervention
Time Frame: Completed immediately post-intervention
World Health Organization Quality of Life - Abbreviated version (WHOQOL-BREF): patient-report of quality of life across domains of physical health, psychological health, social relationships, and environment, using a 5-point likert scale.
Completed immediately post-intervention
Patient quality of life: 1-month post-intervention
Time Frame: Completed 1 month post-intervention
World Health Organization Quality of Life - Abbreviated version (WHOQOL-BREF): patient-report of quality of life across domains of physical health, psychological health, social relationships, and environment, using a 5-point likert scale.
Completed 1 month post-intervention
Patient quality of life: 3-month post-intervention
Time Frame: Completed 3 month post-intervention
World Health Organization Quality of Life - Abbreviated version (WHOQOL-BREF): patient-report of quality of life across domains of physical health, psychological health, social relationships, and environment, using a 5-point likert scale.
Completed 3 month post-intervention
Parenting stress: Baseline
Time Frame: Baseline pre-randomization
Parental Stress Scale (PSS): patient-report of parenting stress across three scales -- parental distress, parent-child dysfunctional interaction, and difficult child -- using a 1 (strongly disagree) - 5 (strongly agree) likert scale
Baseline pre-randomization
Parenting stress: Post-intervention
Time Frame: Completed immediately after the last intervention session
Parental Stress Scale (PSS): patient-report of parenting stress across three scales -- parental distress, parent-child dysfunctional interaction, and difficult child -- using a 1 (strongly disagree) - 5 (strongly agree) likert scale
Completed immediately after the last intervention session
Parenting stress: 1-month post-intervention
Time Frame: Completed 1 month after the last intervention session
Parental Stress Scale (PSS): patient-report of parenting stress across three scales -- parental distress, parent-child dysfunctional interaction, and difficult child -- using a 1 (strongly disagree) - 5 (strongly agree) likert scale
Completed 1 month after the last intervention session
Parenting stress: 3-month post-intervention
Time Frame: Completed 3 months after the last intervention session
Parental Stress Scale (PSS): patient-report of parenting stress across three scales -- parental distress, parent-child dysfunctional interaction, and difficult child -- using a 1 (strongly disagree) - 5 (strongly agree) likert scale
Completed 3 months after the last intervention session
Child mental health: Baseline
Time Frame: Baseline pre-randomization
Strengths and Difficulties Questionnaire (SDQ): Patient-report of child's behavioral functioning across five scales (emotional symptoms, conduct problems, hyperactivity/inattention, peer relationships; and prosocial behaviors) for each of their children using a 3-point likert scale (not true, somewhat true, & certainly true).
Baseline pre-randomization
Child mental health: Post-intervention
Time Frame: Completed immediately after the last intervention session
Strengths and Difficulties Questionnaire (SDQ): Patient-report of child's behavioral functioning across five scales (emotional symptoms, conduct problems, hyperactivity/inattention, peer relationships; and prosocial behaviors) for each of their children using a 3-point likert scale (not true, somewhat true, & certainly true).
Completed immediately after the last intervention session
Child mental health: 1-month post-intervention
Time Frame: Completed 1 month after the last intervention session
Strengths and Difficulties Questionnaire (SDQ): Patient-report of child's behavioral functioning across five scales (emotional symptoms, conduct problems, hyperactivity/inattention, peer relationships; and prosocial behaviors) for each of their children using a 3-point likert scale (not true, somewhat true, & certainly true).
Completed 1 month after the last intervention session
Child mental health: 3-month post-intervention
Time Frame: Completed 3 months after the last intervention session
Strengths and Difficulties Questionnaire (SDQ): Patient-report of child's behavioral functioning across five scales (emotional symptoms, conduct problems, hyperactivity/inattention, peer relationships; and prosocial behaviors) for each of their children using a 3-point likert scale (not true, somewhat true, & certainly true).
Completed 3 months after the last intervention session
Family functioning: Baseline
Time Frame: Baseline pre-randomization
Family Relations Scale: participant-report of family functioning across three scales -- family cohesion, support, and organization -- using a 4-point likert scale (1: not true at all - 4: almost always or always true)
Baseline pre-randomization
Family functioning: Post-intervention
Time Frame: Completed immediately after the last intervention session
Family Relations Scale: patient-report of family functioning across three scales -- family cohesion, support, and organization -- using a 4-point likert scale (1: not true at all - 4: almost always or always true)
Completed immediately after the last intervention session
Family functioning: 1-month post-intervention
Time Frame: Completed 1 month after the last intervention session
Family Relations Scale: patient-report of family functioning across three scales -- family cohesion, support, and organization -- using a 4-point likert scale (1: not true at all - 4: almost always or always true)
Completed 1 month after the last intervention session
Family functioning: 3-month post-intervention
Time Frame: Completed 3 months after the last intervention session
Family Relations Scale: patient-report of family functioning across three scales -- family cohesion, support, and organization -- using a 4-point likert scale (1: not true at all - 4: almost always or always true)
Completed 3 months after the last intervention session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2027

Primary Completion (Estimated)

January 1, 2029

Study Completion (Estimated)

March 1, 2029

Study Registration Dates

First Submitted

January 22, 2026

First Submitted That Met QC Criteria

January 28, 2026

First Posted (Actual)

February 5, 2026

Study Record Updates

Last Update Posted (Actual)

February 5, 2026

Last Update Submitted That Met QC Criteria

January 28, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2024-0990
  • K08MD020100 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified datasets containing quantitative questionnaire data from patient participants will be made available via an open institutional repository. Specific de-identified data elements will include demographic, administrative (condition assignment, attendance, fidelity), clinical (symptom questionnaires about mental health, well being, family, and child functioning), and implementation (intervention acceptability, feasibility) data.

IPD Sharing Time Frame

April 2029 to March 2034

IPD Sharing Access Criteria

Data will be uploaded to an institutional repository that is open to the general public.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Common Elements Treatment Approach (CETA)

Subscribe